Key result
US Medicare MTEER procedural volume jumped nearly 4-fold between 2015 and 2019.
Why the study?
Despite an association between operator volumes and procedural success, contemporary utilization and procedural volumes for MTEER remain incompletely understood.
Observational (n=27,034)
Yes
This study highlights a rapid national expansion and significant geographic variation in MTEER utilization, emphasizing the need to ensure equitable access and optimal operator volumes.
Answers are grounded in this paper and cite their sources.
Marked geographic variation in MTEER access signals inequities; leaves open whether rising operator volumes affect outcomes.
Background: Despite an association between operator volumes and procedural success, there remains an incomplete understanding of the contemporary utilization and procedural volumes for mitral valve transcatheter edge-to-edge repair (MTEER). We aimed to identify annual operator procedural volumes, temporal trends, and geographic variability for MTEER among Medicare patients in the United States (US). Methods: We queried the National Medicare Provider Utilization and Payment Database for a CPT code (33418) specific for MitraClip device from 2015 through 2019. We analyzed annual operator procedural volumes and incidence and identified longitudinal and geographic trends in MTEER utilization. The incidence of MTEER by state varied by nearly 900% (range 5.5 to 54.9 per 100,000 person-years). In 2019, the mean annual MTEER operator annual volume was 9.1 MTEER procedures and had grown from 6.2 per year in 2015. Conclusions: In this nationwide study of Medicare beneficiaries in the United States, we identified a significant and sustained increase in the utilization of MTEER devices and operators and growth in annual procedural volumes from 2015 through 2019 with considerable variability in utilization by state. Further studies are needed to understand the clinical impact of variability in utilization and the optimal procedural volumes to ensure high efficacy outcomes and maintain critical access to MTEER therapies.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2023) conducted an observational in Severe mitral regurgitation (Medicare beneficiaries undergoing MTEER) (n=27,034). Mitral valve transcatheter edge-to-edge repair (MTEER) was evaluated on MTEER procedural volume temporal trend (2015-2019) (283% increase, p=<0.001). MTEER procedural volume among United States Medicare beneficiaries increased by 283% from 2,322 cases in 2015 to 9,021 cases in 2019.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: